DUBLIN–(BUSINESS WIRE)–The “Global Autoinjectors Market, By Therapy By Design By Product By Technology By Type By Route of Administration By End User By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering.
The global autoinjectors market is expected to witness a growth of robust CAGR in the forecast period, 2023-2027.
Companies Mentioned
- Mylan NV
- AbbVie Inc
- Eli Lilly and Company
- Ypsomed Holding AG
- Amgen Inc
- Becton, Dickinson, and Company
- GlaxoSmithKline plc
- Johnson & Johnson International, Inc
- Teva Pharmaceutical Industries Ltd
- Antares Pharma, Inc
- Merck KGaA
- F Hoffmann-LA Roche
- Bayer AG
- Bristol-Myers Squibb Company
- Medeca Pharma AB
Factors such as increased incidence of anaphylaxis and availability of generic autoinjectors in the market are primarily driving the demand for the global autoinjectors market.
The rise in the prevalence of targeted therapies and the shift in preference of consumers for self-administration of drugs are expected to further fuel the market demand in the forecast period. Also, the massive government support and favorable reimbursements and advancements in the healthcare industry are expected to create numerous growth opportunities for the market players in the next five years.
The global autoinjectors market is segmented into therapy, design, product, technology, type, route of administration, end user, regional distribution, and competitive landscape. Based on therapy, the market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others. The rheumatoid arthritis segment is expected to capture the highest market share in the forecast period, 2023-2027. The high prevalence of rheumatoid arthritis worldwide is expected to drive the demand for autoinjectors across the globe.
Years considered for this report:
- Historical Years: 2017-2020
- Base Year: 2021
- Estimated Year: 2022E
- Forecast Period: 2023F-2027F
Objective of the Study:
- To analyze the historical growth in the market size of global autoinjectors market from 2017 to 2021
- To estimate and forecast the market size of global autoinjectors market from 2022E to 2027F and growth rate until 2027F
- To classify and forecast global autoinjectors market based on therapy, design, product, technology, type, route of administration, end user, regional distribution, and competitional landscape
- To identify dominant region or segment in the global autoinjectors market
- To identify drivers and challenges for global autoinjectors market
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global autoinjectors market
- To identify and analyze the profile of leading players operating in global autoinjectors market
- To identify key sustainable strategies adopted by market players in global autoinjectors market
Report Scope:
In this report, global autoinjectors market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global Autoinjectors Market, By Therapy:
- Rheumatoid Arthritis
- Multiple Sclerosis
- Diabetes
- Anaphylaxis
- Others
Global Autoinjectors Market, By Design:
- Standardized
- Customized
Global Autoinjectors Market, By Product:
- Prefilled
- Fillable
Global Autoinjectors Market, By Technology:
- Automated
- Manual
Global Autoinjectors Market, By Type:
- Disposable
- Reusable
Global Autoinjectors Market, By Route of Administrations:
- Intravenous
- Subcutaneous
Global Autoinjectors Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Settings
- Home Care Settings
Global Autoinjectors Market, By Region:
North America
- United States
- Canada
- Mexico
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
South America
- Brazil
- Argentina
- Colombia
For more information about this report visit https://www.researchandmarkets.com/r/np28a7
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900